You can unsubscribe from this list at any time by sending an e-mail message to firstname.lastname@example.org. Put "UNSUBSCRIBE" in the subject line and you will be automatically removed. You can also unsubscribe by going to http://listserv.stellarstocks.com and entering your email address there while selecting unsubscribe.
|April 20, 1999||
Volume II, Issue 14
To Stellarstocks Subscribers:
This is a special update for you on U.S.Microbics (OTC BB: BUGS).
The following news article appeared over the newswire today. In our discussions
with management, we understand that a significant number of Letters of
Intent have been received by the company on behalf of customers
interested in making Bio-Raptor(TM) purchases. The revenue potential of this product to U.S.Microbics is enormous and we believe,based on discussions with management, that the company is about to experience DYNAMIC GROWTH in upcoming quarters.
|Company Press Release
BUGS Bio-Raptor Well-Received at International Bioremediation Conference
CARLSBAD, Calif., April 20 /PRNewswire/ -- Over 1,500 scientists, engineers, consultants, and foreign company representatives are attending the International Insitu Bioremediation Conference in San Diego, where U.S. Microbics, Inc. (OTC Bulletin Board: BUGS - news), is introducing its patented Bio-Raptor(TM) for contaminated soil cleanup, animal waste processing and green waste decomposition applications.
The Bio-Raptor(TM) is portable, street legal, and utilizes proprietary microbial blends with a patented application process to quickly and inexpensively decontaminate soil, decompose green waste, and remove odors, pathogen, and weed seeds from animal effluent.
The Bio-Raptor(TM) a shredder, conveyor, sprayer system is used to particalize soil into small chunks that can easily be sprayed with water containing activated microbial blends. After the contaminated soil passes through the Bio-Raptor(TM) system it is stacked onsite while the microbes break down the hydrocarbon chains into carbon dioxide, water, and other innocuous substances. In many cases, the concentration of the offending contaminates can be reduced to non-detectable levels or levels that meet governmental standards for a non-contaminated classification. Typical contaminants include: diesel fuel, gasoline, oil derivatives, pesticides and sludges, and animal waste streams from horse, cattle, and chicken sources.
The standard Bio-Raptor(TM) has a peak throughput capacity of 600 tons per hour and is ideally suited for portable insitu applications as well as centrally located operations such as a soil or waste-recycling center. The machine is also used worldwide in rock quarries and construction sites for soil screening applications, recycling, and aggregate sizing. Companies with machines similar to the Bio-Raptor(TM) can have their existing equipment retrofitted with the proprietary Microbial Application System to utilize the microbial blends required for bioremediation and waste processing.
``The International Insitu Bioremediation Conference is an excellent opportunity to introduce the Bio-Raptor(TM) and its applications as a high throughput, cost-effective solution for widespread soil contamination and waste problems plaguing our planet,'' said Robert Brehm, BUGS' president and CEO. Brehm indicated that he expected interest from many scientists around the world who wanted to use the Bio-Raptor(TM) for cost-effective, real world applications scaled up from their laboratory experiments. ``Here, at last, is a machine-microbe solution that solves the application problem of providing large surface area (small particle size), proper aeration, and water and microbe application all in a mobile package!'' To further the use of the Bio-Raptor(TM) on a world wide basis, BUGS is offering international licenses and Distributorships for selected applications in selected territories.
For further information about U.S. Microbics and their products contact Ric Eisenberg at 212-496-6828, or Robert Brehm at 760-918-1860 or visit the website at http://bugsatwork.com.
The information contained in this press release includes forward-looking statements. Forward-looking statements usually contain the words ``estimate,'' ``anticipate,'' ``believe,'' ``expect,'' or similar expressions, that involve risks and uncertainties. These risks and uncertainties include the Company's status as a startup company with uncertain profitability, need for significant capital, uncertainty concerning market acceptance of its products, competition, limited service and manufacturing facilities, dependence on technological developments, and protection of its intellectual property. The Company's actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences are discussed more fully in the ``Risk Factors,'' ``Management's Discussion and Analysis or Plan of Operation'' and other sections of the Company's Form 10-KSB and other publicly available information regarding the Company on file with the Securities and Exchange Commission. The Company will provide you with copies of this information upon request.
SOURCE: U.S. Microbics, Inc.
The Stellarstocks.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. All statements and expressions are the sole opinions of the editors and are subject to change without notice. This profile is neither an offer nor solicitation to buy or sell any securities mentioned. This newsletter is owned by SSP Management, Inc, a wholly owned subsidiary of 1st Net Technologies, Inc ("1st Net"). While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. The editor, members of the editor's family, and/or entities with which they are affiliated, may own stock in and have other financial dealings with the companies who appear in the publication. To that degree, this newsletter should not be regarded to be an independent publication. SSP Management has received the following compensation for representing US Microbics for a period of one year: $50,000 in cash, and 50,000 options convertible into restricted stock, exercisable at $1 per share. In a related transaction, SSP Management intends to exercise its option by signing a promissory note to US Microbics for $50,000. The Stellarstocks.com critiques may contain forward looking statements relating to the expected capabilities of the companies mentioned herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STELLARSTOCKS.com.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.